Zusammenfassung
Wenn eine chronisch progrediente, sicher zur terminalen Niereninsuffizienz führende Nierenerkrankung vorliegt, sollte sehr früh nach passenden potenziellen Lebendspendern für eine präemptive Nierenlebendspende gesucht werden. So ist ausreichend Zeit für die Evaluation sowohl von Spender als auch Empfänger vorhanden. Ab einer GFR <30 ml/min kann mit dem Patienten das Thema besprochen werden.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Achilles M (2004) Lebendspende-Nierentransplantation: eine theologisch-ethische Beurteilung, LIT Verlag Münster
Akkina SK; Connaire JJ; Snyder JJ; Matas AJ; Kasiske (2008) Earlier is not necessarily better in preemptive kidney transplantation Am J Transplant. (10):2071–2076
Beimler J et al. (2007) AB0-incompatible transplantation – a safe way to perform renal transplantation? NDT; 22: 25–27
Beimler J, Zeier M (2006) Management von Patienten auf der Transplantationsliste unter besonderer Beachtung immunologischer Aspekte, Mitteilungen der deutschen Arbeitsgemeinschaft für Klinische Nephrologie,XXXV; 83–90
Bloom RD, Olivares M, Rehman L, Raja RM, Yang S, Badosa F (1997) Long-term pancreas allograft outcome in simultaneous pancreas-kidney transplantation: a comparison of enteric and bladder drainage. Transplantation 64:1689–1695
Broeders N, Wissing KM, Crusiaux A, Kinnaert P, Vereerstraeten P, Abramowicz D (1998) Mycophenolate mofetil, together with Ciclosporin A, prevents anti-OKT3 antibody response in kidney transplant recipients. J Am Soc Nephrol 9:1521–1525
Carpenter CB (1990) Immunosuppression in organ transplantation. N Engl J Med 322:1224–1226
Colvin RB, Cohen AH, Saiontz C et al. (1997) Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 8:1930–1941
Delmonico F; Council of the Transplantation Society (2005) A report of the Amsterdam forum on the care of the live kidney donor: Data and medical guidelines. Transplantation;79(6 Suppl):S53–66
Feucht HE, Opelz G (1996) The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 50:1464–1475
First MR, Alloway R, Schroeder TJ (1998) Development of Sang-35: a Ciclosporine formulation bioequivalent to Neoral. Clin Transplant 12:518–524
Fishman JA, Rubin RH (1998) Infection in organ-transplant recipients. N Engl J Med 338:1741–1751
Frei U, Schindler R (2000) Nierentransplantation. In: Koch KM(ED) Klinische Nephrologie. Urban & Fischer, München Jena, S:779–814
Gill JS, Tonelli M, Johnson N, Pereira BJ (2004) Why do preemptive kidney transplant recipients have an allograft survival advantage? Transplantation 78(6):873–879
Hammoud J, Haem J, Laurent B et al (1996) Glomerular diseaseduring HCV infection in renal transplantation. Nephrol Dial Transplant 11:54–58
Jassal SV, Roscoe JM, Zaltzman JS et al. (1998) Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantation. J Am Soc Nephrol 9:1697–1708
Johnson EM et al. (1987) Complications and risks of living donor nephrectomy. Transplantation 64: 1124–1128
Kahan BD, Podbielski J, Napoli KL, Katz SM, Meier-Kriesche HU, Van Buren CT (1998) Immunosuppressive effects and safety of a sirolimus/Ciclosporine combination regimen for renal transplantation. Transplantation 66:1040–1046
Knoll G, Cockfield S, Blydt-Hansen T et al. (2005) Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ 173:1181
Opelz G, Mytilineos J, Scherer S et al. (1993) Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants. Transplantation 55:782–785
Opelz G, Vanrenterghem Y, Kirste G et al. (1997) Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 63:964–967
Pascual M, Saidman S, Tolkoff-Rubin N et al. (1998) Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 66:1460–1464
Patton PR, Brunson ME, Pfaff WW, Howard RJ, Peterson JC, Ramos EL, Karlix JL (1994) A preliminary report of diltiazem and ketoconazole. Their Ciclosporine-sparing effect and impact on transplant outcome. Transplantation 57:889–92
Richtlinien zur Organtransplantation nach § 16 Abs. 1 S. 1 Nrn. 2 und 5 TPG (2007) Dtsch Arztebl 104[46]: A 3208–3209
Sanfilippo F (1998) Transplantation tolerance – the search continues. N Engl J Med 339:1700–1702
Smit H, Molzahn M, Kirste G, Grupp R, Köhler A für die Deutsche Stiftung Organtransplantation (2000) Organspende und Transplantation in Deutschland 1999. 5ter Bericht. Visuelle Kommunikation, Obertiefenbach
Solez K, Axelsen RA, Benediktsson H et al. (1993) International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44:411–422
Sommerer C et al. (2003) The living kidney donor: giving life, avoiding harm. NDT 18: 23–26
Thibaudin D, Alamartine E, de Filippis JP, Diab N, Laurent B, Berthoux F (1998) Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin. Nephrol Dial Transplant 13:711–715
Vella JP, Sayegh MH (1997) Maintenance pharmacological immunosuppressive strategies in renal transplantation. Postgrad Med J 73:386–390
Wuthrich RP, Weinreich T, Ambuhl PM, Schwarzkopf AK, Candinas D, Binswanger U (1999) Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil. Nephrol Dial Transplant 14:394–399
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Geberth, S., Nowack, R. (2014). Vorbereitung zur Nierentransplantation. In: Praxis der Dialyse. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41208-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-41208-0_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41207-3
Online ISBN: 978-3-642-41208-0
eBook Packages: Medicine (German Language)